{"id":957459,"date":"2026-05-04T07:33:54","date_gmt":"2026-05-04T11:33:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/"},"modified":"2026-05-04T07:33:54","modified_gmt":"2026-05-04T11:33:54","slug":"vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/","title":{"rendered":"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BRISBANE, Calif., May  04, 2026  (GLOBE NEWSWIRE) &#8212; Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company\u2019s management team will present at the Bank of America Securities 2026 Health Care Conference, which is taking place in Las Vegas, NV from May 12-14, 2026. The management team will also participate in one-on-one investor meetings.<\/p>\n<p>\n        <strong>Presentation Details:<\/strong><br \/>\n        <br \/>Date: Wednesday, May 13, 2026 <br \/>Time: 4:20 PM PDT <br \/>Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MgN6cyUOOlmeprhsuWEXAWZkw8J7jQxfBOqk_3Yq1fPCqMIw8dBF0CTvAIsyXxEgnPwfCYyKH8_qSkfmctsjZA9BC1VJ39FSr_nzUSoE3XCGWsYcOQIF5NJ3IG7-D1ONUCZR5PPratDHAqVqdnAu0i0oSGo9NYdkMfUMJBU3FSNzHFqnGjW10ubXhTBMlRC65IAlR0R-_yHTzaj67F9fdw==\" rel=\"nofollow\" target=\"_blank\">https:\/\/bofa.veracast.com\/webcasts\/bofa\/healthcare2026\/24Ty86.cfm<\/a><\/p>\n<p>A replay of the event will be available for 90 days and can be accessed by visiting the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bIvFpU0pCVOAQwXVAdQ91xDm2sVTaDZuW2TvWZAfihbJ2zkkVvzeqpujYbl_AcKsc1fbsGmX28jlTsxicQhf1O3NoUyPbTG7JXoFzxmOPvdun5jIGuooJxFUB2y3zj0KTjYorYQ46NicI0b5MDyof5dm2iJhlgM7_DAm_xzZb6Uo_KgiejgivCaGdfY8V7GP94IDtIaouNFHcrTHeVfCDATrIQF-ktA7Ak_ymCBvVk5M1_CAWetqX58X9gKYWw7njOEPJllQinGCe0O1exFYHKvxZN6hfut0CnmhEH2BGIk=\" rel=\"nofollow\" target=\"_blank\">Investor Calendar<\/a>\u201d section of the Vera Therapeutics website.<\/p>\n<p>\n        <strong>About Vera\u00a0Therapeutics\u00a0<\/strong><br \/>\n        <br \/>Vera Therapeutics is a biotechnology company focused on developing treatments for serious immunological diseases.\u00a0Vera Therapeutics\u2019\u00a0mission is to advance treatments that target the source of disease in order to change the standard of care for patients.\u00a0Vera Therapeutics\u2019\u00a0lead product candidate is atacicept, a fusion protein self-administered\u00a0at home\u00a0as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including\u00a0IgA nephropathy (IgAN)\u00a0and lupus nephritis.\u00a0Beyond IgAN, Vera Therapeutics is evaluating\u00a0additional\u00a0diseases where the reduction of autoantibodies by atacicept may prove clinically meaningful.\u00a0In addition, Vera Therapeutics holds an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B-cell\u2013mediated diseases.\u00a0Vera Therapeutics\u00a0is also evaluating the development of MAU868, a monoclonal antibody designed to neutralize infection with BK virus,\u00a0which\u00a0can have devastating consequences in kidney transplant\u00a0recipients.\u00a0Vera Therapeutics\u00a0retains\u00a0all global developmental and commercial rights to atacicept, VT-109, and\u00a0MAU868. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dLnxL8Kovj9hRYnPF3CG-IHIcxtCQ-ofY6ko5IlrrVf66p8AjxY7c1Lq3I3tgvRHIq5FWONxirHFu-vpfwTd74OTgw5gNluzm2eC12wQEfnABKNF1V4Wjo7bqOG4SSIHiZccHNXyRFmEGp31FULCtRzR5PFMqYD91vXLeGo2fsDtqQ_g2mQv6FLCyasYbpB6mlxyTsB0Em_rkdWGjvb9iI0W5O0bfaENwIZMjqa683E=\" rel=\"nofollow\" target=\"_blank\">www.veratx.com<\/a>.\u00a0<\/p>\n<p>\n        <strong>Forward-looking Statements<\/strong><br \/>\n        <br \/>\n        <em>Statements contained in this press release regarding matters, events or results that may occur in the future are \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, Vera Therapeutics\u2019 plans, commitments, aspirations and goals related to its product candidates. Words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cwill\u201d and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Vera Therapeutics\u2019 current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks related to the regulatory approval process, results of earlier clinical trials may not be obtained in later clinical trials, preliminary results may not be predictive of topline results, risks and uncertainties associated with Vera Therapeutics\u2019 business in general, the impact of macroeconomic and geopolitical events, and the other risks described in Vera Therapeutics&#8217; filings with the U.S. Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management\u2019s assumptions and estimates as of such date. Vera Therapeutics undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.<\/em>\u00a0<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Joyce Allaire<br \/>LifeSci Advisors<br \/>212-915-2569<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S68B-2vvYwWM3kXhdeTt4kBJjKpFZ8lKAR2WTSVtTiTrC-4Ppq1hOMo34nxZ2NjxquGKbaY9oRRdnLfyMMqBdnrj7YNJC1Gd5tvY3Tyiah-GYSzqck8AY9wBOIDHzd7m1wk9Sobp0bPi3EU98fFjuzczfmSDgdoSPOyNQVfBMgRTM07nrWtjpvcBuGf_GbRCAnnAtKNaj7C5pGYvUNeFP5EOtMtuz1kJFhxmM7ltyx6ZFlZZfzyunuo4IONG0xrsLT88IIExLhYHmE2XHh8e9DOE1wE0nF8_LKCj1pWtWgKLtQygr7Iu5G1w9ulkZXeJ\" rel=\"nofollow\" target=\"_blank\">jallaire@lifesciadvisors.com<\/a><\/p>\n<p>\n        <strong>Media<\/strong>\u00a0<strong>Contact:<\/strong><br \/>Debra Charlesworth<br \/>Vera Therapeutics<br \/>415-854-8051<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fF8YyN2281wDZa-QHDp7ARul5zu3cphFjCyS6IuIcmHdbfCgOHq1iMc4eKLuHgwNrBTm_C-P3_CwbcopDB9edMq-BoUFvc875rIFbCsZx3TUcBhOBj8cOBhaTiw51yDGyjDXRlAKMqN9LTTojSlQVcMv8I6YcIxeqIjH_avzG_8IlE5-NgtTX8B8hdhI6GVgsPWz__ey8x0Xor6Gq3SE5P9M0ih6m5U_aVYHn-Vmf2-p2v5QBLxtit0VGmsnHHKADLWaig1Yw0BO-hBu-ScYKf2ozhs8i3EJkfnMv8HBGhHNLvStXVPRyNw96azJbJ6H7-KKpX9dLOXtLEKtbczfng==\" rel=\"nofollow\" target=\"_blank\">corporatecommunications@veratx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmIyODM2YjEtODZkYy00YmNjLWFiYjctZDRiOGVlZTY1MTlmLTEyMTkwMjItMjAyNi0wNS0wNC1lbg==\/tiny\/Vera-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRISBANE, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company\u2019s management team will present at the Bank of America Securities 2026 Health Care Conference, which is taking place in Las Vegas, NV from May 12-14, 2026. The management team will also participate in one-on-one investor meetings. Presentation Details: Date: Wednesday, May 13, 2026 Time: 4:20 PM PDT Webcast: https:\/\/bofa.veracast.com\/webcasts\/bofa\/healthcare2026\/24Ty86.cfm A replay of the event will be available for 90 days and can be accessed by visiting the \u201cInvestor Calendar\u201d section of the Vera Therapeutics website. About Vera\u00a0Therapeutics\u00a0 Vera Therapeutics is a biotechnology company focused on developing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-957459","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRISBANE, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company\u2019s management team will present at the Bank of America Securities 2026 Health Care Conference, which is taking place in Las Vegas, NV from May 12-14, 2026. The management team will also participate in one-on-one investor meetings. Presentation Details: Date: Wednesday, May 13, 2026 Time: 4:20 PM PDT Webcast: https:\/\/bofa.veracast.com\/webcasts\/bofa\/healthcare2026\/24Ty86.cfm A replay of the event will be available for 90 days and can be accessed by visiting the \u201cInvestor Calendar\u201d section of the Vera Therapeutics website. About Vera\u00a0Therapeutics\u00a0 Vera Therapeutics is a biotechnology company focused on developing &hellip; Continue reading &quot;Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-04T11:33:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference\",\"datePublished\":\"2026-05-04T11:33:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/\"},\"wordCount\":585,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/\",\"name\":\"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=\",\"datePublished\":\"2026-05-04T11:33:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - Market Newsdesk","og_description":"BRISBANE, Calif., May 04, 2026 (GLOBE NEWSWIRE) &#8212; Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company\u2019s management team will present at the Bank of America Securities 2026 Health Care Conference, which is taking place in Las Vegas, NV from May 12-14, 2026. The management team will also participate in one-on-one investor meetings. Presentation Details: Date: Wednesday, May 13, 2026 Time: 4:20 PM PDT Webcast: https:\/\/bofa.veracast.com\/webcasts\/bofa\/healthcare2026\/24Ty86.cfm A replay of the event will be available for 90 days and can be accessed by visiting the \u201cInvestor Calendar\u201d section of the Vera Therapeutics website. About Vera\u00a0Therapeutics\u00a0 Vera Therapeutics is a biotechnology company focused on developing &hellip; Continue reading \"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-04T11:33:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference","datePublished":"2026-05-04T11:33:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/"},"wordCount":585,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/","name":"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=","datePublished":"2026-05-04T11:33:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxMTU4MSM3NTc4Njc3IzIyMDc0Njk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vera-therapeutics-to-participate-in-the-bank-of-america-securities-2026-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=957459"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/957459\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=957459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=957459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=957459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}